Literature DB >> 28595471

Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades.

Tiantian Sun1, Shuncong Wang2, Huanhuan Sun2, Jianguo Wen3, Gang An4, Juan Li1.   

Abstract

Multiple myeloma (MM) is estimated to have 30,280 new cases and be associated with 12,590 deaths in 2017. However, quantitative analysis for survival, based on a large population, is lacking. Data were extracted from a total of 33,170 cases from nine registry sites in the Surveillance, Epidemiology, and End Results database. The current study shows that the incidence for MM remained relatively stable between 1981 and 2010, with 4.6, 4.7, and 4.7 per 100,000 persons in each decade. In addition, survival for MM improved each decade with a larger increment in the last two decades, with a narrowing survival gap among races and a widening gap among socioeconomic status (SES) groups. The survival gap changes in races and SES groups may guide clinicians to design better treatment protocols and call for the pressing need for health-care policy to fill the gap among SES groups.

Entities:  

Keywords:  Multiple myeloma; SEER; incidence; socioeconomic status; survival

Mesh:

Year:  2017        PMID: 28595471     DOI: 10.1080/10428194.2017.1335398

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

1.  Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare.

Authors:  Jifang Zhou; Karen Sweiss; Edith A Nutescu; Jin Han; Pritesh R Patel; Naomi Y Ko; Todd A Lee; Brian C-H Chiu; Gregory S Calip
Journal:  JCO Oncol Pract       Date:  2021-01-15

2.  The Epidemiological Trend of Acute Myeloid Leukemia in Childhood: a Population-Based Analysis.

Authors:  Xuanwei Chen; Jianwei Pan; Shuncong Wang; Shandie Hong; Shunrong Hong; Shaoru He
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207

Review 3.  A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed.

Authors:  Shuncong Wang; Yewei Liu; Yuanbo Feng; Jian Zhang; Johan Swinnen; Yue Li; Yicheng Ni
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

Review 4.  Socioeconomic Status is Globally a Prognostic Factor for Overall Survival of Multiple Myeloma Patients: Synthesis of Studies and Review of the Literature.

Authors:  Stergios Intzes; Marianthi Symeonidou; Konstantinos Zagoridis; Zoe Bezirgianidou; Georgios Vrachiolias; Athina Spanoudaki; Emmanouil Spanoudakis
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

5.  Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients.

Authors:  Samilia Obeng-Gyasi; Noah Graham; Shaji Kumar; Ju-Whei Lee; Susanna Jacobus; Matthias Weiss; David Cella; Fengmin Zhao; Edward H Ip; Nathaniel O'Connell; Fangxin Hong; Devin J Peipert; IIana F Gareen; Lava R Timsina; Robert Gray; Lynne I Wagner; Ruth C Carlos
Journal:  Blood Cancer J       Date:  2022-04-01       Impact factor: 9.812

6.  Socioeconomic status-based survival disparities and nomogram prediction for patients with multiple myeloma: Results from American and Chinese populations.

Authors:  Jiaxuan Xu; Peipei Xu; Qiaoyan Han; Jingjing Sun; Bing Chen; Xiaoqing Dong
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

Review 7.  Liquid biopsies for multiple myeloma in a time of precision medicine.

Authors:  Bruna Ferreira; Joana Caetano; Filipa Barahona; Raquel Lopes; Emilie Carneiro; Bruno Costa-Silva; Cristina João
Journal:  J Mol Med (Berl)       Date:  2020-04-04       Impact factor: 4.599

8.  Incidence and mortality of multiple myeloma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016.

Authors:  Jiangmei Liu; Weiping Liu; Lan Mi; Xinying Zeng; Cai Cai; Jun Ma; Lijun Wang
Journal:  J Hematol Oncol       Date:  2019-12-10       Impact factor: 17.388

9.  Epidemiological Trends of Head and Neck Cancer: A Population-Based Study.

Authors:  Kangwen Guo; Weiliang Xiao; Xinggui Chen; Zhenying Zhao; Yuanxiong Lin; Ge Chen
Journal:  Biomed Res Int       Date:  2021-07-14       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.